CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | −5,894 | $5.43 | $32K | 180,093 |
| 2026-03-02 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −5,566 | $5.42 | $30K | 154,161 |
| 2026-03-02 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −4,339 | $5.42 | $24K | 182,625 |
| 2026-03-02 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | −5,820 | $5.43 | $32K | 123,582 |
| 2026-03-02 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −5,565 | $5.42 | $30K | 170,700 |
| 2026-02-18 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | −5,290 | $5.10 | $27K | 123,487 |
| 2026-02-18 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −7,857 | $5.11 | $40K | 97,227 |
| 2026-02-18 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −6,225 | $5.10 | $32K | 124,464 |
| 2026-02-18 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | −5,290 | $5.10 | $27K | 73,152 |
| 2026-02-18 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −7,851 | $5.11 | $40K | 113,765 |
| 2025-07-14 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −1,116 | $2.58 | $3K | 105,084 |
| 2025-07-14 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,117 | $2.58 | $3K | 121,616 |
| 2025-07-14 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −853 | $2.61 | $2K | 130,689 |
| 2025-02-18 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | −5,521 | $2.96 | $16K | 33,479 |
| 2025-02-18 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | −5,515 | $2.97 | $16K | 83,814 |
| 2025-02-18 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −8,345 | $2.91 | $24K | 61,237 |
| 2025-02-18 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −6,618 | $2.95 | $20K | 86,579 |
| 2025-02-18 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −6,912 | $2.92 | $20K | 77,770 |
| 2025-02-13 | Love Douglas PRESIDENT AND CEO | Sale | −5,021 | $2.95 | $15K | 351,554 |
| 2025-02-13 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,786 | $2.98 | $5K | 84,682 |
Page 1 of 4 · 70 trades